会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Tumor grading and cancer prognosis
    • 肿瘤分级和癌症预后
    • US09447470B2
    • 2016-09-20
    • US12718973
    • 2010-03-06
    • Mark G. ErlanderXiao-Jun MaDennis C. Sgroi
    • Mark G. ErlanderXiao-Jun MaDennis C. Sgroi
    • C12Q1/68
    • C12Q1/6886C12Q2600/106C12Q2600/112
    • The disclosure includes the identification and use of gene expression profiles, or patterns, with clinical relevance to cancer. In particular, the disclosure includes the identities of genes that are expressed in correlation with tumor grade. The levels of gene expression are disclosed as a molecular index for determining tumor grade in a patient and predicting clinical outcome, and so prognosis, for the patient. The molecular grading of cancer may optionally be used in combination with a second molecular index for diagnosing cancer and its prognosis. The disclosure further includes methods for predicting cancer recurrence, and/or predicting occurrence of metastatic cancer. For diagnosis or prognosis, the disclosure further includes methods for determining or selecting the treatment of cancer based upon the likelihood of life expectancy, cancer recurrence, and/or cancer metastasis.
    • 该公开内容包括鉴定和使用与癌症具有临床相关性的基因表达谱或模式。 特别地,本公开包括与肿瘤等级相关表达的基因的身份。 公开了基因表达水平作为确定患者肿瘤分级的分子指标,并预测了患者的临床结果以及预后。 癌症的分子分级可以任选地与用于诊断癌症及其预后的第二分子指数组合使用。 本公开还包括用于预测癌症复发和/或预测转移性癌症发生的方法。 为了诊断或预后,本公开还包括基于预期寿命,癌症复发和/或癌症转移的可能性来确定或选择癌症治疗的方法。
    • 9. 发明申请
    • TUMOR GRADING AND CANCER PROGNOSIS
    • 肿瘤分级和癌症预后
    • US20110136680A1
    • 2011-06-09
    • US12718973
    • 2010-03-06
    • Mark G. ErlanderXiao-Jun MaDennis Sgroi
    • Mark G. ErlanderXiao-Jun MaDennis Sgroi
    • C12Q1/68C40B30/00
    • C12Q1/6886C12Q2600/106C12Q2600/112
    • The disclosure includes the identification and use of gene expression profiles, or patterns, with clinical relevance to cancer. In particular, the disclosure includes the identities of genes that are expressed in correlation with tumor grade. The levels of gene expression are disclosed as a molecular index for determining tumor grade in a patient and predicting clinical outcome, and so prognosis, for the patient. The molecular grading of cancer may optionally be used in combination with a second molecular index for diagnosing cancer and its prognosis. The disclosure further includes methods for predicting cancer recurrence, and/or predicting occurrence of metastatic cancer. For diagnosis or prognosis, the disclosure further includes methods for determining or selecting the treatment of cancer based upon the likelihood of life expectancy, cancer recurrence, and/or cancer metastasis.
    • 该公开内容包括鉴定和使用与癌症具有临床相关性的基因表达谱或模式。 特别地,本公开包括与肿瘤等级相关表达的基因的身份。 公开了基因表达水平作为确定患者肿瘤分级的分子指标,并预测了患者的临床结果以及预后。 癌症的分子分级可以任选地与用于诊断癌症及其预后的第二分子指数组合使用。 本公开还包括用于预测癌症复发和/或预测转移性癌症发生的方法。 为了诊断或预后,本公开还包括基于预期寿命,癌症复发和/或癌症转移的可能性来确定或选择癌症治疗的方法。